Pre-Approval Access to Golimumab Subcutaneous for the Treatment of Stage 3 Type-1 Diabetes Mellitus in Children and Young Adults
Clinical trial NCT03945903 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT03945903
- Sponsor
- Janssen Research & Development, LLC
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.